• No se han encontrado resultados

Alzheimers’ Disease

Immunotherapy of Alzheimers disease pdf

Immunotherapy of Alzheimers disease pdf

... AN1792, a synthetic version of protein βA142, was formulated together with an adjuvant (QS-21). [QS-21 is a mixture of tri-terpenic glycosides purified from the bark of Quillaja saponaria (QS, derived from the generic ...

21

Alzheimers disease, from the past into the future pdf

Alzheimers disease, from the past into the future pdf

... In the current situation, for each monetary unit invested in research into Alzheimer’s disease, society spends 3.5 monetary units in the care of this sick. Thus, investing in research is a bet for the future. The ...

8

The Role of Insulin Resistance and Glucose Metabolism Dysregulation in the Development of Alzheimers Disease

The Role of Insulin Resistance and Glucose Metabolism Dysregulation in the Development of Alzheimers Disease

... Alzheimer´s disease is a chronic neurodegenerative disorder affecting millions of people worldwide, characterized by a progressive decline in cognitive ...Alzheimer´s disease include metabolic alterations ...

6

Omental transplantation on the carotid bifurcation and anterior perforated space for Alzheimers disease

Omental transplantation on the carotid bifurcation and anterior perforated space for Alzheimers disease

... are initiated generally starting from 30 years of age. Becau- se, in contrast to this, the revascularization by means of omental tissue produces rejuvenation, cause decrease or normalization in hyperglycemia and it can ...

6

An overview of repetitive transcranial magnetic stimulation (rTMS) in Alzheimers disease

An overview of repetitive transcranial magnetic stimulation (rTMS) in Alzheimers disease

... The studies presented in this review suggest the thera- peutic potential of rTMS in patients with mild to moderate AD by observing the effects that benefit some of the cogni- tive domains affected by AD, improve the ...

8

New Potential Drug for Alzheimers Disease pdf

New Potential Drug for Alzheimers Disease pdf

... A significant side effect of Adacunumab was a kind of encephalitis known by the acronym ARIA (Amyloid-Related Imaging Abnormalities) [4] which causes headache, diarrhoea and dizziness; and this is not related to the dose ...

6

Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease.

Drug-induced autoimmune liver disease: A diagnostic dilemma of an increasingly reported disease.

... the disease can be triggered in susceptible patients by external factors such as viruses or ...liver disease (DIAILD): AIH with drug-induced liver injury (DILI); drug induced-AIH (DI- AIH); and immune ...

10

Association between cholecystectomy for gallstone disease and risk factors for cardiovascular disease

Association between cholecystectomy for gallstone disease and risk factors for cardiovascular disease

... Univariate analysis demonstrated that patients undergoing cholecystectomy had increased risk of T2DM (OR 2.3, 95% CI 1.19-4.5, p = 0.01), high BP (OR 4.9, 95% CI 2.5-9.3, p < 0.001), and dyslipidae- mia (OR 2.1, 95% ...

5

New Perspectives on Oxidized Genome Damage and Repair Inhibition by Pro-Oxidant Metals in Neurological Diseases

New Perspectives on Oxidized Genome Damage and Repair Inhibition by Pro-Oxidant Metals in Neurological Diseases

... Despite an enormous increase in our understanding of the neuropathological events in aging and in ~200 types of neurological conditions, there is no cure available; current treatments slow progressive dementia only ...

26

Diagnosis of Chagas' disease

Diagnosis of Chagas' disease

... For epidemiological studies, serodiagnosis techniques also require the highest sensitivity. Positive predictive val- ues depend upon the prevalence of antibodies in the human population. Furthermore, to be efficient, a ...

9

Nonalcoholic fatty liver disease

Nonalcoholic fatty liver disease

... Nonalcoholic fatty liver disease is a clinicopathologic syndrome that encompasses several clinical entities. The spectrum of conditions ranges from simple ste- atosis to steatohepatitis, fibrosis and end stage ...

8

Management of Kawasaki disease

Management of Kawasaki disease

... s disease it is recom- mended that these are avoided in those with cerebral vasculitis since there is a concern that this class of drug may exacerbate vasculitic complications in some ...

11

Fontan Associated Liver Disease: A Review

Fontan Associated Liver Disease: A Review

... liver disease is a hepatic disorder arising from hemodynamic changes and systemic venous congestion following Fontan ...liver disease. While the natural history of this form of liver disease is not ...

13

Alteraciones en resonancia magnética de pacientes con enfermedad de Parkinson y Parkinson plus

Alteraciones en resonancia magnética de pacientes con enfermedad de Parkinson y Parkinson plus

... Los más comúnmente empleados con la actualidad son los propuestos por la UK Parkinson´s Disease Society Brain Bank: CRITERIOS DIAGNÓSTICOS DEL UK PARKINSON´S DISEASE SOCIETY BRAIN BANK D[r] ...

65

Polycystic liver disease: a clinical review

Polycystic liver disease: a clinical review

... unknown, but like polycystin 1 and 2, it is contai- ned in the primary cilia of both the kidney and liver, and is implicated in cystogenesis. Unfortunately, ARPKD is associated with a high mortality rate, and many ...

8

New aspects in celiac disease

New aspects in celiac disease

... There are many unanswered questions about CD. What is responsible for the collapse of CD oral tolerance? Restoring immunological tolerance to gluten would represent the ideal way to treat or cure this disease. ...

6

Monitoring Neurological disease in Phonation

Monitoring Neurological disease in Phonation

... In section 4 the application of this methodology to the detection and grading of a kind of neurological al- teration of voice known as spasmodic dysphonia which presents neuromuscular [r] ...

12

Orthostatic hypotension in Parkinson's disease

Orthostatic hypotension in Parkinson's disease

... progressive degeneration of the dopaminergic nigrostriatal pathway, but also of many other central and peripheral neuronal systems [4]. The involvement of dopamine and non-dopaminergic systems is responsible for the ...

44

Melatonin and human cardiovascular disease

Melatonin and human cardiovascular disease

... In humans, exogenous melatonin has been shown to decrease nocturnal hypertension, improve systolic and diastolic blood pressure, reduce the pulsatility index in the internal carotid arte[r] ...

28

Alcoholic liver disease  An update

Alcoholic liver disease An update

... TNF- α agents (infliximab and etanercept) potentially interfere with an important mechanistic pathway of ALD. Excessive consumption of alcohol leads to the genera- tion of oxidative cellular stress and injury from ...

12

Show all 1527 documents...

Related subjects